Fundraising Fox
/Companies
Sign in

BioSurfaces

Ashland, US · Founded 2018 · Massachusetts LLC · 1 known investors

Find your way into BioSurfaces

Each arrow is one introduction. Sign up to fill in the first one.

78 people can intro you to Matthew

Ask Graham Gardner to introduce you to Matthew D. Phaneuf

You →Graham · together at Beth Israel Deaconess Medical Center →Matthew

25 people can intro you to Tina

Ask Jamie Chen to introduce you to Tina M Phaneuf

You →Jamie · together at University of Massachusetts Dartmouth →Tina

Sign up to find every way you can get introduced to BioSurfaces

  • Your email: who you already know at BioSurfaces, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BioSurfaces team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

BioSurfaces develops medical devices, 3D tissue engineering scaffolds, and personal care products using its proprietary Bio-Spun nanofiber technology. The company works in the medical device and tissue engineering space, with collaborations that include Takeda, NIH, and Corning.

BiotechMedical DevicesNew Materials

Founders & leadership

BioSurfaces was founded in 2018 by Tina M Phaneuf and Matthew D. Phaneuf.

TM
Tina M PhaneufExecutive Officer and Director of ManagerTina Phaneuf brings 23 years of experience in textile materials research and development, with particular focus on biomedical applications, and has spent the past 13 years managing operations including finance, procurement, and budget oversight at BioSurfaces.
MDMatthew D. Phaneuf
Matthew D. PhaneufCo-founder · President and CEOMatthew D. Phaneuf is an executive with expertise in biomaterials, tissue engineering, and medical device development. He holds six issued patents in biomaterial synthesis and cell encapsulation, has authored over 30 peer-reviewed publications, and previously secured $6.6 million in federal small business grants to advance platform technology.

Board

TL
Thomas L BarretteDirector of Manager

Investors · 1

Reported raises · per SEC filings

Form D private placements

$900K disclosed across 1 round · 2018

▶$900KraisedMar 2018 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tina M PhaneufExecutive Officer, Director
  • Matthew D. PhaneufExecutive Officer, Director
  • Thomas L BarretteDirector
Amount sold
$900K
Minimum investment
$25K
Proceeds to insiders
$150K
First sale
Mar 2018
Incorporated
Limited Liability Company, Massachusetts, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

BiomericsBiomerics is a vertically integrated contract manufacturer for interventional medical devices, offering engineering, materials, and process expertise through 12 facilities. The company serves original equipment manufacturers in the medical device market with comprehensive design-to-manufacturing capabilities.
Imbed BiosciencesImbed Biosciences is a medical device company that develops SAMatrix, an ultra-thin, fully synthetic bioresorbable wound matrix that integrates antimicrobial silver and non-opioid pain agents (lidocaine) for treating chronic and acute wounds such as ulcers, surgical, traumatic, and burn wounds. Its product portfolio includes Surgaflex, Pelashield, and Microlyte, along with PainGuard variants.

Companies working in the same space as BioSurfaces.

Non-dilutive funding · 16 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$884.7K
National Institutes of Health (NIH)National Institutes of HealthPhase I2023$275.8K
National Institutes of Health (NIH)National Institutes of HealthPhase I2014$150K
National Institutes of Health (NIH)National Institutes of HealthPhase II2012$988.1K
National Institutes of Health (NIH)National Institutes of HealthPhase IISTTR2011$749K
National Institutes of Health (NIH)National Institutes of HealthPhase I2010$111.1K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2009$110.5K
National Institutes of Health (NIH)National Institutes of HealthPhase I2008$500K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2008$100K
National Science FoundationPhase ISTTR2007$150K
National Institutes of Health (NIH)National Institutes of HealthPhase II2006$744.6K
National Institutes of Health (NIH)National Institutes of HealthPhase IISTTR2006$744.6K
National Institutes of Health (NIH)National Institutes of HealthPhase II2005$750K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2004$100K
National Institutes of Health (NIH)National Institutes of HealthPhase I2004$100K
National Institutes of Health (NIH)National Institutes of HealthPhase I2003$200K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

BioSurfaces Receives $2.06 Million Grant to Advance Development of Bio-Spun™ Cell Chamber Device - BioSpacebiospace.com · Nov 2024

Frequently asked questions

What does BioSurfaces do?
BioSurfaces develops medical devices, 3D tissue engineering scaffolds, and personal care products using its proprietary Bio-Spun nanofiber technology. The company works in the medical device and tissue engineering space, with collaborations that include Takeda, NIH, and Corning.
Who founded BioSurfaces?
BioSurfaces was founded by Tina M Phaneuf, Matthew D. Phaneuf in 2018.
Who are BioSurfaces's investors?
BioSurfaces's investors include Bill & Melinda Gates Foundation.
How much funding has BioSurfaces raised?
BioSurfaces has disclosed $900K raised across 1 round.
Where is BioSurfaces headquartered?
BioSurfaces is headquartered in Ashland, US.